Mustang Cash vs Short Long Term Debt Total Analysis
MBIO Stock | USD 0.20 0.01 4.76% |
Mustang Bio financial indicator trend analysis is infinitely more than just investigating Mustang Bio recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Mustang Bio is a good investment. Please check the relationship between Mustang Bio Cash and its Short Long Term Debt Total accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mustang Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Mustang Stock, please use our How to Invest in Mustang Bio guide.
Cash vs Short Long Term Debt Total
Cash vs Short Long Term Debt Total Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Mustang Bio Cash account and Short Long Term Debt Total. At this time, the significance of the direction appears to have very week relationship.
The correlation between Mustang Bio's Cash and Short Long Term Debt Total is 0.22. Overlapping area represents the amount of variation of Cash that can explain the historical movement of Short Long Term Debt Total in the same time period over historical financial statements of Mustang Bio, assuming nothing else is changed. The correlation between historical values of Mustang Bio's Cash and Short Long Term Debt Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash of Mustang Bio are associated (or correlated) with its Short Long Term Debt Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Long Term Debt Total has no effect on the direction of Cash i.e., Mustang Bio's Cash and Short Long Term Debt Total go up and down completely randomly.
Correlation Coefficient | 0.22 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Cash
Cash refers to the most liquid asset of Mustang Bio, which is listed under current asset account on Mustang Bio balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Mustang Bio customers. The amounts must be unrestricted with restricted cash listed in a different Mustang Bio account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.Short Long Term Debt Total
Most indicators from Mustang Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Mustang Bio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mustang Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Mustang Stock, please use our How to Invest in Mustang Bio guide.As of the 3rd of June 2024, Selling General Administrative is likely to drop to about 9 M. In addition to that, Issuance Of Capital Stock is likely to drop to about 155.8 K
Mustang Bio fundamental ratios Correlations
Click cells to compare fundamentals
Mustang Bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Mustang Bio fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Other Current Liab | 236K | 3.8M | 9.2M | (270K) | 8.3M | 8.7M | |
Total Current Liabilities | 7.8M | 9.5M | 10.8M | 15.1M | 15.4M | 9.2M | |
Total Stockholder Equity | 51.7M | 98.4M | 112.4M | 46.3M | 123K | 116.9K | |
Net Tangible Assets | 36.4M | 51.7M | 98.4M | 112.4M | 129.3M | 135.7M | |
Net Debt | (45.9M) | (95.6M) | (107.6M) | (44.3M) | (3.7M) | (3.9M) | |
Retained Earnings | (125.5M) | (185.5M) | (251.8M) | (329.4M) | (381.0M) | (361.9M) | |
Accounts Payable | 2.5M | 9.2M | 10.5M | 14.5M | 6.3M | 6.5M | |
Common Stock Shares Outstanding | 2.4M | 3.5M | 5.9M | 6.9M | 8.6M | 5.3M | |
Non Current Liabilities Total | 14.0M | 2.0M | 2.0M | 31.0M | 2.2M | 2.1M | |
Capital Surpluse | 98.7M | 113.4M | 172.2M | 276.0M | 317.4M | 333.2M | |
Other Stockholder Equity | 172.2M | 276.0M | 359.9M | 374.5M | 380.5M | 223.5M | |
Total Liab | 21.8M | 11.5M | 12.8M | 46.1M | 17.6M | 15.5M | |
Total Assets | 73.4M | 109.9M | 125.2M | 92.4M | 17.7M | 16.9M | |
Cash | 61.4M | 97.8M | 109.6M | 75.7M | 6.2M | 5.9M | |
Non Current Assets Total | 10.4M | 10.4M | 13.5M | 13.6M | 6.4M | 8.8M | |
Other Assets | 771K | 1.3M | 2.8M | 1.4M | 1.6M | 1.3M | |
Cash And Short Term Investments | 61.4M | 97.8M | 109.6M | 75.7M | 6.2M | 5.9M | |
Retained Earnings Total Equity | (48.4M) | (79.1M) | (125.5M) | (185.5M) | (166.9M) | (158.6M) | |
Liabilities And Stockholders Equity | 73.4M | 109.9M | 125.2M | 92.4M | 17.7M | 16.9M | |
Total Current Assets | 63.1M | 99.5M | 111.7M | 78.9M | 11.3M | 10.8M | |
Accumulated Other Comprehensive Income | 4.9M | 7.9M | 4.3M | 1.1M | 591K | 561.5K | |
Property Plant Equipment | 9.1M | 9.1M | 12.1M | 12.3M | 14.2M | 8.0M | |
Property Plant And Equipment Net | 9.1M | 9.1M | 12.1M | 12.3M | 4.8M | 8.8M | |
Net Receivables | 19K | 15K | 50K | 36K | 3.9M | 4.1M | |
Other Current Assets | 1.6M | 1.7M | 2.0M | 3.2M | 1.2M | 1.7M | |
Net Invested Capital | 65.1M | 98.4M | 112.4M | 73.7M | 123K | 116.9K | |
Property Plant And Equipment Gross | 9.1M | 9.1M | 12.1M | 12.3M | 9.3M | 9.5M | |
Net Working Capital | 55.3M | 90.0M | 100.9M | 63.7M | (4.0M) | (3.8M) | |
Capital Stock | 4K | 7K | 9K | 11K | 1K | 950.0 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mustang Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Mustang Stock, please use our How to Invest in Mustang Bio guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Complementary Tools for Mustang Stock analysis
When running Mustang Bio's price analysis, check to measure Mustang Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mustang Bio is operating at the current time. Most of Mustang Bio's value examination focuses on studying past and present price action to predict the probability of Mustang Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mustang Bio's price. Additionally, you may evaluate how the addition of Mustang Bio to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
Is Mustang Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mustang Bio. If investors know Mustang will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mustang Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.37) | Revenue Per Share (0) | Return On Assets (0.56) | Return On Equity (3.22) |
The market value of Mustang Bio is measured differently than its book value, which is the value of Mustang that is recorded on the company's balance sheet. Investors also form their own opinion of Mustang Bio's value that differs from its market value or its book value, called intrinsic value, which is Mustang Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mustang Bio's market value can be influenced by many factors that don't directly affect Mustang Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mustang Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mustang Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mustang Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.